Your browser doesn't support javascript.
loading
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021.
Kotton, Camille N; Torre-Cisneros, Julián; Aguado, José Maria; Alain, Sophie; Baldanti, Fausto; Baumann, Gabriele; Boeken, Udo; de la Calle, Maria; Carbone, Javier; Ciceri, Fabio; Comoli, Patrizia; Couzi, Lionel; Danziger-Isakov, Lara; Fernández-Ruiz, Mario; Girmenia, Corrado; Grossi, Paolo Antonio; Hirsch, Hans H; Humar, Atul; Kamar, Nassim; Kotton, Camille; Ljungman, Per; Malagola, Michele; Mira, Estefania; Mueller, Nicolas; Sester, Martina; Teng, Chieh-Lin Jerry; Torre-Cisneros, Julian; Ussetti, Piedad; Westall, Glen; Wolf, Dana; Zamora, Marty.
Afiliación
  • Kotton CN; Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Torre-Cisneros J; Maimónides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofía University Hospital/University of Cordoba (UCO), Cordoba, Spain.
  • Alain S; University Hospital 12 de Octubre, CIBERINFEC, ISCIII - CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Baldanti F; French References Center for Herpes Viruses, Microbiology Department, CHU-Limoges, Limoges, France.
  • Baumann G; Università di Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Boeken U; Landeskrankenhaus Steyr, Steyr, Austria.
  • de la Calle M; Department of Cardiac Surgery, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Germany.
  • Carbone J; La Paz Hospital, Madrid, Spain.
  • Ciceri F; Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Comoli P; IRCCS San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milan, Italy.
  • Couzi L; Cell Factory and Center for Advanced Therapies and Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Danziger-Isakov L; Department of Nephrology, Transplantation, Dialysis and Apheresis, CHU Bordeaux CNRS-UMR 5164 ImmunoConcEpT, Bordeaux University, Bordeaux, France.
  • Fernández-Ruiz M; Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, USA.
  • Girmenia C; University Hospital 12 de Octubre, Madrid, Spain.
  • Grossi PA; AOU Policlinico Umberto I, Rome, Italy.
  • Hirsch HH; Università degli Studi dell'Insubria - ASST SetteLaghi, Varese, Italy.
  • Humar A; University Hospital Basel, Basel, Switzerland.
  • Kamar N; University of Toronto, Toronto, Canada.
  • Kotton C; Toulouse University Hospital, Toulouse, France.
  • Ljungman P; Massachusetts General Hospital, Boston, USA.
  • Malagola M; Karolinska Hospital and Karolinska Institute, Stockholm, Sweden.
  • Mira E; University of Brescia, Brescia, Italy.
  • Mueller N; Reina Sofía University Hospital, Cordoba, Spain.
  • Sester M; Universitäts Spital Zürich, Zürich, Switzerland.
  • Teng CJ; Universität des Saarlandes, Homburg, Germany.
  • Torre-Cisneros J; Taichung Veterans General Hospital, Taichung, Taiwan.
  • Ussetti P; Reina Sofía University Hospital, Cordoba, Spain.
  • Westall G; Hospital Puerta de Hierro Majadahonda, Madrid, Spain.
  • Wolf D; Alfred Hospital, Melboune, Australia.
  • Zamora M; Hadassah University Medical Center, Jerusalem, Israel.
Transpl Infect Dis ; 24(6): e13977, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36271650
ABSTRACT
The CMV Symposium in September 2021 was an international conference dedicated to cytomegalovirus (CMV) infection after solid organ or hematopoietic stem cell transplantation. This review provides an overview of the presentations given by the expert faculty, supplemented with educational clinical cases. Topics discussed include CMV epidemiology and diagnosis, the burden of CMV infection and disease, CMV-specific immunity and management of CMV in transplant settings. Major advances in the prevention and treatment of CMV in the past decade and increased understanding of CMV immunity have led to improved patient outcomes. In the future, management algorithms may be individualized based on the transplant recipient's immune profile, which will mark the start of a new era for patients with CMV.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Órganos / Trasplante de Pulmón / Infecciones por Citomegalovirus / Trasplante de Células Madre Hematopoyéticas Límite: Humans Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Órganos / Trasplante de Pulmón / Infecciones por Citomegalovirus / Trasplante de Células Madre Hematopoyéticas Límite: Humans Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos